🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

Recruitingn/aAges any - anyAllXi'an No.3 Hospital
NCT03607565 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study focus on a new parameter of cerebral perfusion derived form digital substraction angiography.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Cerebral ischemia 2. patients undergone DSA Exclusion Criteria: 1.cerebral hemorrhage
💊

What it tests

  • Not listed
📍

Where

1 site
Xi'an No.3 Hospital
Xi'an, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy